iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine
Liver transplantation is the most common treatment for patients suffering from liver failure that is caused by congenital diseases, infectious agents, and environmental factors. Despite a high rate of patient survival following transplantation, organ availability remains the key limiting factor. As...
Main Authors: | Cristina Olgasi, Alessia Cucci, Antonia Follenzi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/21/17/6215 |
Similar Items
-
Generation of Hepatobiliary Cell Lineages from Human Induced Pluripotent Stem Cells: Applications in Disease Modeling and Drug Screening
by: Mattia Pasqua, et al.
Published: (2021-07-01) -
Cellular heterogeneity and plasticity during NAFLD progression
by: Hyun-Ju Park, et al.
Published: (2023-08-01) -
Bilirubin-Induced Neurological Damage: Current and Emerging iPSC-Derived Brain Organoid Models
by: Abida Islam Pranty, et al.
Published: (2022-08-01) -
Integration of iPSC-Derived Microglia into Brain Organoids for Neurological Research
by: Muhammad Asif Mrza, et al.
Published: (2024-03-01) -
Modeling brain macrophage biology and neurodegenerative diseases using human iPSC-derived neuroimmune organoids
by: Jonas Cerneckis, et al.
Published: (2023-06-01)